BusinessPhoto: Mint MarketsGland Pharma Shares Hit 52-Week High, Rise 7% Amid Market Fall
Gland Pharma shares surged over 6.73% to a 52-week high of ₹3,352 on November 9, despite a broader market decline. The stock opened at ₹3,147 on NSE, up from ₹3,132.80. The company reported a 58.2% YoY net profit increase to ₹291 crore in Q2 FY27, with revenue rising 23.3% to ₹1,834 crore and EBITDA up 54.1% to ₹484 crore, improving margins to 26.4%.
Mint Markets·



